SEC Tracker
Get the app

TrueBlue TBI

TrueBlue FY 2024: net loss $125.7M; diluted EPS −$4.17

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers TrueBlue reported for the year ended Dec 29, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$125.7MAgainst −$14.2M in FY 202310-K income statement, on EDGAR
  2. Diluted EPS−$4.17Against −$0.45 in FY 202310-K income statement, on EDGAR
  3. Cash and cash equivalents$22.5M−64% from $61.9M in FY 202310-K balance sheet, on EDGAR
  4. Cash from operations−$17.1M−149% from $34.8M in FY 202310-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when TrueBlue files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 7363 and related industry codes: the same peer list as the financial tables.

  1. Heidrick & Struggles International HSII
  2. Kelly Services KELYA public float $364M, Jun 29, 2025
  3. Cross Country Healthcare CCRN public float $393M, Jun 30, 2025
  4. RCM Technologies RCMT public float $99M, Jun 27, 2025
  5. Circle8 Group ATLN public float $98M, Jun 30, 2025